DeRoyal Angio Cath Removal Tray, REF 89-9936.02
FDA Device Recall #Z-1834-2021 — Class I — May 14, 2021
Recall Summary
| Recall Number | Z-1834-2021 |
| Classification | Class I — Serious risk |
| Date Initiated | May 14, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | DeRoyal Industries Inc |
| Location | Powell, TN |
| Product Type | Devices |
| Quantity | 60 trays |
Product Description
DeRoyal Angio Cath Removal Tray, REF 89-9936.02
Reason for Recall
DeRoyal manufactured certain lots of surgical procedure pack products using Hospira Pfizer 1% Lidocaine which was subsequently recalled due to mislabeling; the product is 0.5% Bupivacaine
Distribution Pattern
US Nationwide distribution to the states of MS, VA, LA, and NY.
Lot / Code Information
Lot Numbers: 54368716, exp. 6/01/2022
Other Recalls from DeRoyal Industries Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1291-2025 | Class II | DeRoyal REF 71-C5100NS Tubing, Suction, Connect... | Jan 31, 2025 |
| Z-1174-2025 | Class II | DeRoyal AMG Suction Connector Tubing REF: 71-2... | Jan 15, 2025 |
| Z-0306-2025 | Class II | DeRoyal C-SECTION TRACEPACK, REF 89-9338-06 | Oct 3, 2024 |
| Z-0307-2025 | Class II | DeRoyal CHILDREN'S GENERAL TRACEPACK, REF 89-93... | Oct 3, 2024 |
| Z-0308-2025 | Class II | DeRoyal CHILDREN'S ORTHOPEDIC TRACEPACK, 89-934... | Oct 3, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.